The Therapeutics Goods Administration (TGA) has made an interim decision to expand the current Schedule 5 entry for lidocaine, to include specifically targeted injectable solutions, at up to 2 per cent concentration, for the pain relief of lambs or calves undergoing animal husbandry procedures. The AVA made a submission opposing this, which was entered in […]